BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29466231)

  • 1. Transcytosis of payloads that are non-covalently complexed to bispecific antibodies across the hCMEC/D3 blood-brain barrier model.
    Schmid D; Buntz A; Hanh Phan TN; Mayer K; Hoffmann E; Thorey I; Niewöhner J; Vasters K; Sircar R; Mundigl O; Kontermann RE; Brinkmann U
    Biol Chem; 2018 Jun; 399(7):711-721. PubMed ID: 29466231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood-brain barrier in vitro is dependent on its binding affinity.
    Haqqani AS; Thom G; Burrell M; Delaney CE; Brunette E; Baumann E; Sodja C; Jezierski A; Webster C; Stanimirovic DB
    J Neurochem; 2018 Sep; 146(6):735-752. PubMed ID: 29877588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human blood-brain barrier transcytosis assay reveals antibody transcytosis influenced by pH-dependent receptor binding.
    Sade H; Baumgartner C; Hugenmatter A; Moessner E; Freskgård PO; Niewoehner J
    PLoS One; 2014; 9(4):e96340. PubMed ID: 24788759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Perfused In Vitro Human iPSC-Derived Blood-Brain Barrier Faithfully Mimics Transferrin Receptor-Mediated Transcytosis of Therapeutic Antibodies.
    Burgio F; Gaiser C; Brady K; Gatta V; Class R; Schrage R; Suter-Dick L
    Cell Mol Neurobiol; 2023 Nov; 43(8):4173-4187. PubMed ID: 37698826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs.
    Pornnoppadol G; Bond LG; Lucas MJ; Zupancic JM; Kuo YH; Zhang B; Greineder CF; Tessier PM
    Cell Chem Biol; 2024 Feb; 31(2):361-372.e8. PubMed ID: 37890480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
    Markoutsa E; Pampalakis G; Niarakis A; Romero IA; Weksler B; Couraud PO; Antimisiaris SG
    Eur J Pharm Biopharm; 2011 Feb; 77(2):265-74. PubMed ID: 21118722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy.
    De Jong E; Williams DS; Abdelmohsen LKEA; Van Hest JCM; Zuhorn IS
    J Control Release; 2018 Nov; 289():14-22. PubMed ID: 30243824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain penetration, target engagement, and disposition of the blood-brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1.
    Webster CI; Caram-Salas N; Haqqani AS; Thom G; Brown L; Rennie K; Yogi A; Costain W; Brunette E; Stanimirovic DB
    FASEB J; 2016 May; 30(5):1927-40. PubMed ID: 26839377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain uptake of multivalent and multi-specific DVD-Ig proteins after systemic administration.
    Karaoglu Hanzatian D; Schwartz A; Gizatullin F; Erickson J; Deng K; Villanueva R; Stedman C; Harris C; Ghayur T; Goodearl A
    MAbs; 2018 Jul; 10(5):765-777. PubMed ID: 29771629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-chain fragment constant design enables easy production of a monovalent blood-brain barrier transporter and provides an improved brain uptake at elevated doses.
    Morrison JI; Metzendorf NG; Rofo F; Petrovic A; Hultqvist G
    J Neurochem; 2023 May; 165(3):413-425. PubMed ID: 36681883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target.
    Yu YJ; Zhang Y; Kenrick M; Hoyte K; Luk W; Lu Y; Atwal J; Elliott JM; Prabhu S; Watts RJ; Dennis MS
    Sci Transl Med; 2011 May; 3(84):84ra44. PubMed ID: 21613623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the transcytosis of an anti-transferrin receptor antibody with a Fab' cargo across the blood-brain barrier in mice.
    Manich G; Cabezón I; del Valle J; Duran-Vilaregut J; Camins A; Pallàs M; Pelegrí C; Vilaplana J
    Eur J Pharm Sci; 2013 Jul; 49(4):556-64. PubMed ID: 23748097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical PKPD and safety model of bispecific TfR/BACE1 antibodies for the optimization of antibody uptake in brain.
    Gadkar K; Yadav DB; Zuchero JY; Couch JA; Kanodia J; Kenrick MK; Atwal JK; Dennis MS; Prabhu S; Watts RJ; Joseph SB; Ramanujan S
    Eur J Pharm Biopharm; 2016 Apr; 101():53-61. PubMed ID: 26820920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating receptor-mediated antibody transcytosis using blood-brain barrier organoid arrays.
    Simonneau C; Duschmalé M; Gavrilov A; Brandenberg N; Hoehnel S; Ceroni C; Lassalle E; Kassianidou E; Knoetgen H; Niewoehner J; Villaseñor R
    Fluids Barriers CNS; 2021 Sep; 18(1):43. PubMed ID: 34544422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hapten-directed spontaneous disulfide shuffling: a universal technology for site-directed covalent coupling of payloads to antibodies.
    Dengl S; Hoffmann E; Grote M; Wagner C; Mundigl O; Georges G; Thorey I; Stubenrauch KG; Bujotzek A; Josel HP; Dziadek S; Benz J; Brinkmann U
    FASEB J; 2015 May; 29(5):1763-79. PubMed ID: 25670234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered hapten-binding antibody derivatives for modulation of pharmacokinetic properties of small molecules and targeted payload delivery.
    Dengl S; Sustmann C; Brinkmann U
    Immunol Rev; 2016 Mar; 270(1):165-77. PubMed ID: 26864111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants.
    Bien-Ly N; Yu YJ; Bumbaca D; Elstrott J; Boswell CA; Zhang Y; Luk W; Lu Y; Dennis MS; Weimer RM; Chung I; Watts RJ
    J Exp Med; 2014 Feb; 211(2):233-44. PubMed ID: 24470444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro Blood-Brain barrier model based on recombinant spider silk protein nanomembranes for evaluation of transcytosis capability of biomolecules.
    Hjelm LC; Hedhammar M; Löfblom J
    Biochem Biophys Res Commun; 2023 Aug; 669():77-84. PubMed ID: 37267863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
    Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
    Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody screening using a human iPSC-based blood-brain barrier model identifies antibodies that accumulate in the CNS.
    Georgieva JV; Goulatis LI; Stutz CC; Canfield SG; Song HW; Gastfriend BD; Shusta EV
    FASEB J; 2020 Sep; 34(9):12549-12564. PubMed ID: 32960493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.